Index Entries

Safi Alqatari, Mona Ismail, Manal Hasan, Raed Bukhari, Reem Al Argan, Abrar Alwaheed, Dania Alkhafaji, Syed Essam Ahmed, Kawther Hadhiah, Turki Alamri, Ameera Nemer, Fedaa Albeladi,
Noor N. Bumurah, Khalid Sharofna, Zainab Albaggal, Raghad Alghamdi, and Reem S. Al Sulaiman
March 4, 2023
Infection and Drug Resistance
Imam Abdulrahman Bin Faisal University (Saudi Arabia)

"Methods: Data were obtained from one center in the eastern province of Saudi Arabia (King Fahd Hospital of University). All patient events reported occurred in the study period March 2021 to February 2022. We identified patients presenting with autoimmune diseases with exclusively new onset presentations.

Results: We identified 31 cases of immune-mediated disease: 18 females (58%); 13 males (42%). Only 4 of them (13%) had an autoimmune background before COVID-19 vaccination. The average time between vaccination and new-onset disease symptoms was 7 days. Among all the cases in our study, 7 patients (22.5%) had new-onset vasculitis, 2 cases had IgA vasculitis and 5 cases had ANCA vasculitis, 6 cases had neurological diseases (19.3%), 4 cases (12.9%) had new-onset systemic lupus erythematosus (SLE), 3 cases (9.6%) presented with new-onset inflammatory arthritis, and one had Sjogren’s syndrome (3.2%).

Conclusion: Our study is unique as it is the first study to include the largest number (31 patients) of new onsets of confirmed autoimmune diseases related to Covid-19 vaccines."

document
adverse events,autoimmunity,COVID-19,neurological disorders,vaccines